Goldman Sachs Group Inc Tyra Biosciences, Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 78,006 shares of TYRA stock, worth $827,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,006
Previous 78,006
-0.0%
Holding current value
$827,643
Previous $725,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$113 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$44 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$43.3 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$43 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$43 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $445M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...